1Kelly J,Rudd A,Lewis R. Venous thromboembolism after acute stroke[J].{H}STROKE,2001,(1):262-267.
2Kubitza D,Becka M,Mueck W. Safety,tolerability,pharmacodynamics,and pharmacokinetics of rivaroxaban-an oral,direct factor Xa inhibitor-are not affected by aspirin[J].{H}Journal of Clinical Pharmacology,2006,(9):981-990.
3Eriksson B I,Borris L C,Friedman R J. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty[J].{H}New England Journal of Medicine,2008,(26):2765-2775.
4Kakkra A K,Brenner B,Dahl O E. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty:a doubleblind,randomized controlled trial[J].{H}LANCET,2008,(9632):31-39.
5Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomized trials of antiplatelet therapy for precention of death,myocardial infarction,and stroke in high risk patients[J].{H}BMJ:British Medical Journal,2002,(7329):71-86.
